Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Journal of Inflammatory Diseases
  4. Articles

  5. Seroprevalence of Toxoplasma gondii among females referred to Qazvin community-based medicine center for pre-marriage examinations
  6. Scopus by Title (Ref)

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

homeHome
play_arrowCurrent IssuetimelineAll Issuesfact_checkIn Pressfact_checkAccepted ManuscriptssearchSearch
lightbulbInstructions
monitor_heartJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesquery_statsJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice StatementschoolReviewer and AE Registration Formsupport_agentSupportphoneContact Us
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Study of Serological toxoplasmosis and risk factors associated with infection in women referred to labs of Northern Tehran, Iran

- Ghadamgahi F. , et al.

2. Interlaboratory and interkit evaluation of ELISA test for detection of specific IgG antibodies of Toxoplasma gondii

- Saraei M. , et al.

HomeInstructions

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.